Since the outbreak of pneumonia in the new crown pneumonia, because of its rapid spread, strong infectivity and long incubation period, sick people and people with weak resistance are easily infected, the mortality rate is relatively high and the treatment cost is very high. Since the outbreak of the Wuhan epidemic in China, the state has invested a lot of money and manpower to fight the epidemic, and all confirmed patients and suspected patients have been treated first and then resettled. After the settlement of medical insurance, the rest of the patients' treatment expenses are subsidized by the finance according to regulations, and the patients' self-funded expenses are particularly small, which provides a solid guarantee for China to fight the epidemic.
According to the data given by the National Medical Insurance Bureau, as of July 19, 2020, there were135,500 cases of confirmed and suspected patients in COVID-19, China, with the designed medical expenses18.47 million yuan and the medical insurance payment12.32 million yuan, and the payment ratio reached 67%. However, in 20 19, the individual financing of medical insurance for urban and rural residents in China was only about 800 yuan, which was still relatively low. At the same time, due to the large number of people vaccinated in COVID-19, the total cost is high, which obviously exceeds the affordability of the medical insurance fund.
Judging from the reply of the National Medical Insurance Bureau, it is really unreasonable for medical insurance to bear the vaccine cost in full. Judging from China's current per capita income, the cost of vaccination at one's own expense is still affordable, and countries with poor populations who do have difficulties will still give corresponding subsidies so that everyone can be vaccinated. I believe that everyone will also respect the decision of the country and follow the final decision of the country.